Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cytosorbents (CTSO) Interest & Investment Income (2016 - 2025)

Cytosorbents (CTSO) has disclosed Interest & Investment Income for 14 consecutive years, with -$645000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Interest & Investment Income fell 9.69% year-over-year to -$645000.0, compared with a TTM value of -$2.5 million through Sep 2025, down 201.04%, and an annual FY2024 reading of -$1.4 million, down 786.11% over the prior year.
  • Interest & Investment Income was -$645000.0 for Q3 2025 at Cytosorbents, down from -$616000.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $53752.0 in Q4 2022 and bottomed at -$645000.0 in Q3 2025.
  • Average Interest & Investment Income over 5 years is -$171716.2, with a median of -$10124.0 recorded in 2021.
  • The sharpest move saw Interest & Investment Income surged 337.22% in 2022, then crashed 8995.66% in 2025.
  • Year by year, Interest & Investment Income stood at $12294.0 in 2021, then soared by 337.22% to $53752.0 in 2022, then tumbled by 197.17% to -$52229.0 in 2023, then plummeted by 1095.1% to -$624189.0 in 2024, then fell by 3.33% to -$645000.0 in 2025.
  • Business Quant data shows Interest & Investment Income for CTSO at -$645000.0 in Q3 2025, -$616000.0 in Q2 2025, and -$605134.0 in Q1 2025.